Solid-phase synthesis of deglycobleomycin and bleomycin

Christopher J. Leitheiser, Sidney Hecht

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

The bleomycins are a group of structurally related glycopeptide antibiotics originally isolated from Streptomyces verticillus in the 1960s. They are used for the treatment of cancers including Hodgkin's lymphomas, carcinomas of the skin, head and neck, and testicular tumors. Whereas analogs of bleomycin have been synthesized to facilitate an understanding of its biochemical properties, the complexity of the molecule has severely limited the total number of analogs synthesized. The solid-phase synthesis of fully functional and active deglycobleomycin and bleomycin analogs is described. This approach has resulted in the synthesis of over 160 unique deglycobleomycin and bleomycin analogs in the past two years, an accomplishment that would not have been possible without the solid-phase methodology.

Original languageEnglish (US)
Pages (from-to)827-837
Number of pages11
JournalCurrent Opinion in Drug Discovery and Development
Volume6
Issue number6
StatePublished - Nov 2003
Externally publishedYes

Fingerprint

Solid-Phase Synthesis Techniques
Bleomycin
Glycopeptides
Testicular Neoplasms
Streptomyces
Hodgkin Disease
Neck
Head
Anti-Bacterial Agents
Carcinoma
Skin
deglycobleomycin
Neoplasms

Keywords

  • Bleomycin
  • Combinatorial synthesis
  • Deglycobleomycin
  • DNA
  • RNA
  • Solid-phase synthesis

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology
  • Drug Discovery

Cite this

Solid-phase synthesis of deglycobleomycin and bleomycin. / Leitheiser, Christopher J.; Hecht, Sidney.

In: Current Opinion in Drug Discovery and Development, Vol. 6, No. 6, 11.2003, p. 827-837.

Research output: Contribution to journalArticle

@article{027f865f46a240a089afe0ce183427b9,
title = "Solid-phase synthesis of deglycobleomycin and bleomycin",
abstract = "The bleomycins are a group of structurally related glycopeptide antibiotics originally isolated from Streptomyces verticillus in the 1960s. They are used for the treatment of cancers including Hodgkin's lymphomas, carcinomas of the skin, head and neck, and testicular tumors. Whereas analogs of bleomycin have been synthesized to facilitate an understanding of its biochemical properties, the complexity of the molecule has severely limited the total number of analogs synthesized. The solid-phase synthesis of fully functional and active deglycobleomycin and bleomycin analogs is described. This approach has resulted in the synthesis of over 160 unique deglycobleomycin and bleomycin analogs in the past two years, an accomplishment that would not have been possible without the solid-phase methodology.",
keywords = "Bleomycin, Combinatorial synthesis, Deglycobleomycin, DNA, RNA, Solid-phase synthesis",
author = "Leitheiser, {Christopher J.} and Sidney Hecht",
year = "2003",
month = "11",
language = "English (US)",
volume = "6",
pages = "827--837",
journal = "Current Opinion in Drug Discovery and Development",
issn = "1367-6733",
publisher = "Current Drugs Ltd.",
number = "6",

}

TY - JOUR

T1 - Solid-phase synthesis of deglycobleomycin and bleomycin

AU - Leitheiser, Christopher J.

AU - Hecht, Sidney

PY - 2003/11

Y1 - 2003/11

N2 - The bleomycins are a group of structurally related glycopeptide antibiotics originally isolated from Streptomyces verticillus in the 1960s. They are used for the treatment of cancers including Hodgkin's lymphomas, carcinomas of the skin, head and neck, and testicular tumors. Whereas analogs of bleomycin have been synthesized to facilitate an understanding of its biochemical properties, the complexity of the molecule has severely limited the total number of analogs synthesized. The solid-phase synthesis of fully functional and active deglycobleomycin and bleomycin analogs is described. This approach has resulted in the synthesis of over 160 unique deglycobleomycin and bleomycin analogs in the past two years, an accomplishment that would not have been possible without the solid-phase methodology.

AB - The bleomycins are a group of structurally related glycopeptide antibiotics originally isolated from Streptomyces verticillus in the 1960s. They are used for the treatment of cancers including Hodgkin's lymphomas, carcinomas of the skin, head and neck, and testicular tumors. Whereas analogs of bleomycin have been synthesized to facilitate an understanding of its biochemical properties, the complexity of the molecule has severely limited the total number of analogs synthesized. The solid-phase synthesis of fully functional and active deglycobleomycin and bleomycin analogs is described. This approach has resulted in the synthesis of over 160 unique deglycobleomycin and bleomycin analogs in the past two years, an accomplishment that would not have been possible without the solid-phase methodology.

KW - Bleomycin

KW - Combinatorial synthesis

KW - Deglycobleomycin

KW - DNA

KW - RNA

KW - Solid-phase synthesis

UR - http://www.scopus.com/inward/record.url?scp=0346458779&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0346458779&partnerID=8YFLogxK

M3 - Article

C2 - 14758754

AN - SCOPUS:0346458779

VL - 6

SP - 827

EP - 837

JO - Current Opinion in Drug Discovery and Development

JF - Current Opinion in Drug Discovery and Development

SN - 1367-6733

IS - 6

ER -